Virologic outcomes are attenuated in AZD1222 vaccinees with breakthrough infections
Analyses of SARS-CoV-2 viral loads in nasopharyngeal swabs and saliva samples revealed a trend towards lower GMT in vaccinees compared with placebo recipients at all timepoints throughout the illness period (Virologic outcomes to breakthrough infection are attenuated in AZD1222 vaccinees compared to unvaccinated. 